baber/WOPTO huggingface dataset:
Patent PT-1250822-E (PT)
Inventor: ACHIM VON BRANDT
IPC: H04W16/00
Filed: 2001-01-25
Abstract: The invention relates to a radio communication system in which the channel assignment is signaled from a base station control to a base station. The inventive method is further characterized in that in at least one base station a data base is established in which at least one channel combination is stored, said channel combination being accessible by means of an assigned address.
Patent PT-1269484-E (PT)
Title: Cable tape and method for manufacturing a cable tape
Inventor: KOHN FREDERIK EMIEL
IPC: D04H1/40
Filed: 2001-04-03
Abstract: The invention relates to a cable tape, based on at least one fibrous web, in which fibrous web at least 0.5% by weight, calculated on the weight of the cable tape, of thermoplastic microspheres which may or may not be partly or wholly expanded and, if desired, an effective amount of a water-swelling powder is incorporated, and to a method for the manufacture of such a tape and to cable manufactured using the tape.
Patent PT-1337505-E (PT)
Title: A process for the preparation of n,n`-substituted 5-amino-1,3-benzenedicarboxamides
Inventor: BROCCHETTA MARINO
IPC: C07C237/32
Filed: 2001-11-28
Abstract: The invention relates to a process for the preparation of a compound of formula (I), wherein R represents a 2,3-dihydroxy-1-propyl or a 1,3-dihydroxy-2-propyl radical, via direct amidation of a dialkyl ester of 5-amino-1,3-benzenedicarboxylic acid of formula (V), wherein R<SUB>1 </SUB>represents a straight or branched (C<SUB>1</SUB>-C<SUB>4</SUB>)-alkyl group, with at least the stoichiometric amount of an amine of formula H<SUB>2</SUB>NR.
Patent PT-1419152-E (PT)
Title: Hiv inhibiting pyrimidines derivatives
Inventor: LEWI PAULUS JOANNES
IPC: A61K31/541
Filed: 2002-08-09
Abstract: This invention concerns HIV replication inhibitors of formula   
the  N -oxides, the pharmaceutically acceptable addition salts, the quaternary amines and the stereochemically isomeric forms thereof, wherein the ring containing -a 1 =a 2 -a 3 =a 4 - and -b 1 =b 2 -b 3 =b 4 - represents phenyl, pyridyl, pyrimidinyl, pirazinyl, pyridazinyl;n is 0 to 5; m is 1 to 4; R 1  is hydrogen; aryl; formyl; C 1-6 alkylcarbonyl; C 1-6 alkyl; C 1-6 alkyloxycarbonyl; substituted C 1-6 alkyl, C 1-6 alkylcarbonyl, C 1-6 alkyloxycarbonyl, C 1-6 alkylcarbonyloxy; substituted C 1-6 alkyloxyC 1-6 alkylcarbonyl; R 2  is hydroxy, halo, optionally substituted C 1-6 alkyl, C 3-7 cycloalkyl, optionally substituted C 2-6 alkenyl, optionally substituted C 2-6 alkynyl, C 1-6 alkyloxy, C 1-6 alkyloxycarbonyl, carboxyl, cyano, nitro, amino, mono-or di(C 1-6 alkyl)amino, polyhalomethyl, polyhalomethyloxy, polyhalomethylthio, - S(=O) p R 6 , -NH-S(=O) p R 6 , -C(=O)R 6 , -NHC(=O)H, -C(=O)NHNH 2 , -NHC(=O)R 6  -C(=NH)R 6  or a 5-membered heterocycle; X 1  is -NR 5 -, -NH-NH-, -N=N-, -O-, -C(=O)-, C 1-4 alkanediyl, -CHOH-, -S-, -S(=O) p -, -X 2 -C 1-4 alkanediyl- or -C 1-4 alkanediyl-X 2 -; R 3  is NHR 13 ; NR 13 R 14 ; -C(=O)-NHR 13 ; -C(=O)-NR 13 R 14 ; -C(=O)-R 15 ; -CH=N-NH-C(=O)-R 16 ; substituted C 1-6 alkyl; optionally substituted C 1-6 alkyloxyC 1-6 alkyl; substituted C 2-6 alkenyl; substituted C 2-6 alkynyl; C 1-6 alkyl substituted with hydroxy and a second substituent; -C(=N-O-R 8 )-C 1-4 alkyl; R 7 ; or -X 3 -R 7 ; R 4  is halo, hydroxy, C 1-6 alkyl, C 3-7 cycloalkyl, C 1-6 alkyloxy, cyano, nitro, polyhaloC 1-6 alkyl, polyhatoC 1-6 alkyloxy, aminocarbonyl, C 1-6 alkyloxycarbonyl, C 1-6 alkylcarbonyl, formyl, amino, mono- or di(C 1-4 alkyl)amino; their use as a medicine, their processes for preparation and pharmaceutical compositions comprising them.
Patent PT-1435326-E (PT)
Title: Partition assembly for container
Inventor: BEDEZ GILLES
IPC: B65D5/49
Filed: 2003-12-23
Abstract: The cross work has two cross work modules (10, 20) that are linked by a longitudinal cut of a groove (34) forming a hinge (30) between them. The modules are made of rigid panels (101) of undulate cartons. The module (10) is brought down on the module (20) based on a shaft (R) and the modules are in intermediary folding position in chisel. The modules are folded on their edges based on a distorted parallelogram mechanism.  An Independent claim is also included for a container having a majority of cross-works.
Patent PT-1568602-E (PT)
Title: Auxiliary propulsion unit using the deviation of a fluid stream
Inventor: GMBH WOLFGANG JOBMANN
IPC: B63H9/02
Filed: 2004-02-24
Abstract: The unit has a rotary, horizontally arranged cylinder with end plates. A fluid stream channel connects to the rotor, in order to produce the propulsion in a desired direction. The fluid stream is directed to a channel and its flow direction meets the rotor to produce the propulsion in a desired direction. The movement takes place upwards or downwards.
Patent PT-1419789-E (PT)
Title: Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these
Inventor: BISHOP JOHN E
IPC: A61K49/00
Filed: 1999-01-14
Abstract: The present invention describes processes for the preparation of a lipid blend and a uniform filterable phospholipid suspension containing the lipid blend, such suspension being useful as an ultrasound contrast agent. Preparation of the lipid blend The lipid blend may be prepared via an aqueous suspension-lyophilization process or an organic solvent dissolution-precipitation process using organic solvents. In the aqueous suspension-lyophilization process, the desired lipids are suspended in water at an elevated temperature and then concentrated by lyophilization. Preferably a dissolution procedure is used.
Patent PT-1447604-E (PT)
Title: Method for the burying of tubular elements and mortar composition for carrying out this method
Inventor: LAFFITE HELENE
IPC: F16L1/036
Filed: 2004-02-12
Abstract: The procedure, especially for laying plastic gas pipes (2), consists of excavating a trench (1) and holding the pipe down with metal arches (7) while the trench is back-filled with a mortar (6), the arches leaving sufficient room for the pipe to rise and create a gap underneath that if filled with the liquid mortar. The procedure, especially for laying plastic gas pipes (2), consists of excavating a trench (1) and holding the pipe down with metal arches (7) while the trench is back-filled with a mortar (6), the arches leaving sufficient room for the pipe to rise and create a gap underneath that if filled with the liquid mortar. The mortar is designed to be self-compacting, chemically inert relative to the plastic pipes, resistant to frost when set, and able to withstand a pressure of at least 2 MPa; it can contain natural and/or synthetic fibres and is mixed with a water/ cement ration of between 0.8 and 2 : 1.
Patent PT-1651986-E (PT)
Title: Optical article comprising a multilayer anti-reflective coating and method for production thereof
Inventor: BITEAU JOHN
IPC: C09D183/08
Filed: 2004-07-28
Abstract: The invention relates to an optical article, for example, an ophthalmic lens, comprising at least one multilayer anti-reflective coating on a transparent substrate made from organic or mineral glass. Said coating comprises successively and starting at the substrate, a layer of material with high refractive index (HI), made from a hybrid organic/inorganic matrix within which are dispersed particles of mineral oxide or chalcogenide with a diameter of 2 to 50 nm and a layer of material with low refractive index (BI), obtained by hardening of a composition comprising at least one silane precursor (I) with 4 hydrolysable groups and at least one fluorosilane precursor (II), said second composition comprising at least 10% in mass of fluorine in a theoretical dry extract and with a molar ratio I/I+II greater than 80%.
Patent PT-1761273-E (PT)
Title: Treatment of non alcoholic steatotic hepatitis (nash)
Inventor: DEVENTER SANDER JAN HENDRIK VAN
IPC: A61K38/46
Filed: 2005-06-20
Abstract: The present invention relates to a method for treating non-alcoholic steatotic hepatitis (NASH) in a subject by administering an effective amount of a lipoprotein lipase (LPL) therapeutic to the subject. The LPL therapeutic is advantageously a S447X protein or a derivative or variant thereof, or a nucleic acid encoding such a protein. The LPL therapeutic may be used in a gene therapy vector.
Patent PT-1951343-E (PT)
Title: Attachment for a syringe or cartridge
Inventor: GLOCKER JOACHIM
IPC: A61M5/32
Filed: 2006-11-10
Abstract: The invention relates to an attachment for a syringe or cartridge having a cannula, wherein the attachment comprises a sealing element, which is molded onto the cannula.
Patent PT-2145064-E (PT)
Title: Protective shelter
Inventor: HESELDEN JAMES
IPC: E04H9/10
Filed: 2008-04-18
Abstract: A protective shelter that can provide protection within a war zone and which can be readily assembled in a readily assembled in a quick, secure and reliable manner. The shelter is formed of opposite outer walls and a roof structure extending therebetween, wherein the roof structure comprises a plurality of tray members supported by beam supports and in which the plurality of tray members is arranged to receive earth, sand or aggregate material so as to provide a first layer of protection via the roof structure. The tray members can be supported by beams serving to define a shallow arch across the shelter such that the internal height of the shelter centrally, and away from the opposite walls, is greater than the height of the said walls.
Patent PT-2205019-E (PT)
Title: Method and system for accessing a core network node
Inventor: SUN YAFEI
IPC: H04W28/08
Filed: 2009-12-30
Abstract: A method and a system for accessing core network (CN) nodes and an access device thereof are provided. The method includes: selecting (11,311,411) a CN node to be accessed by an access point (AP) according to a preset mapping relationship between the APs and the CN nodes when receiving a service request from the AP; and sending (13) the service request to the selected CN node. Moreover, the CN node is not required to support the Iu-flex function. 
In an embodiment, an access gateway, AG, establishes a mapping relationship between registration information about the AP(s) and the CN nodes. 
Thereby, the registration information about the AP(s) includes: 
an equipment ID of the AP, AP-ID, a mobile network ID of the AP, PLMN-ID, an area ID of a macro network where the AP is located or of the AP, e.g. LAC, RAC, SAC, or information about the geographic location of the AP or about the broadband fixed network that the AP accesses, e.g. an ADSL port number or IP address.
Patent PT-2459557-E (PT)
Title: Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals
Inventor: STEINHAGEN HENNING
IPC: A61K31/437
Filed: 2010-07-23
Abstract: The present invention relates to cyclic indolizinecarboxamides and azaindolizinecarboxamides of the formulae Ia and Ib, wherein R, Ra, R10, R20, R30, R40, Y, n, p and q have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. Specifically, they inhibit the enzyme renin and modulate the activity of the renin-angiotensin system, and are useful for the treatment of diseases such as hypertension, for example. The invention furthermore relates to processes for the preparation of the compounds of the formulae Ia and Ib, their use and pharmaceutical compositions comprising them.
Patent PT-592685-E (PT)
Inventor: ISHIDA ISAO
IPC: C12N5/10
Filed: 1993-04-16
Abstract: A process for preparing a plant which is resistant to two or more RNA viruses by integrating into a plant chromosome a DNA sequence coding for a protein having an enzymatic activity of specifically decomposing a double-stranded RNA and expressing the same; and a plant resistant to RNA viruses which is prepared thereby.
Patent PT-635025-E (PT)
Inventor: KENT STEPHEN B H
IPC: C07K14/16
Filed: 1993-03-26
Abstract: Processes for the preparation of modified proteins comprising the coupling of a first peptide segment having a haloacyl group at the N-terminus thereof with a second peptide sequent having a carbonylthiol group at the C-terminus thereof are disclosed. Novel modified proteins produced by the process are also disclosed.
Patent PT-642342-E (PT)
Inventor: LEVY JULIA
IPC: A61K41/00
Filed: 1993-05-27
Abstract: Treatment with a set of porphyrin compounds using a photodynamic therapy approach is able selectively to lower elevated levels of activated leukocytes in a leukocyte population. This is particularly helpful in subjects containing such elevated levels of T-cell subsets, such as HIV-infected subjects.
Patent PT-689459-E (PT)
Inventor: NORTH JOHN ROBERT
IPC: A61K47/48
Filed: 1994-03-18
Abstract: This invention describes a novel agent for the targeted control of a mammalian cell activity, in particular the agent is used to control the interaction of particular cell types with their external environment. The agent has applications as a pharmaceutical for the treatment of a variety of disorders. An agent according to the invention comprises three Domains B, T and E linked together in the following manner: Domain B-Domain T-Domain E where Domain B is the Binding Domain which binds the agent to a Binding Site on the cell which undergoes endocytosis to produce an endosome, Domain T is the Translation Domain which translocates the agent (with or without the Binding Site) from within the endosome across the endosomal membrane into the cytosol of the cell, Domain E is the Effector Domain which inhibits the ability of the Recyclable Membrane Vesicles to transport the Integral Membrane Proteins to the surface of the cell.
Patent PT-696548-E (PT)
Inventor: NAKAMURA MASATO
IPC: B41J35/28
Filed: 1994-11-01
Abstract: In an autochanger which can continuously operate a video printing apparatus without having recourse to intervention by an operator, a paper feed tray for containing a plurality of recording media and/or an ink ribbon cartridge are loaded in the video printer device such as to selectively change them as the occasion demands, and a magazine which can contain a plurality of paper feed trays and/or ink ribbon cartridges and a conveyance means of paper feed tray and/or ink ribbon cartridge for conveying the paper feed tray and/or the ink ribbon cartridge between the video printer device and the magazine, are provided. Therefore, the paper feed tray and the ink ribbon cartridge of the video printer device can be changed by the conveyance means as the occasion demands, so as to realize an autochanger which can continuously operate a video printer device without having recourse to intervention by an operator. <MATH>
Patent PT-727045-E (PT)
Inventor: HELLER MICHAEL J
IPC: C12Q1/6825
Filed: 1994-10-26
Abstract: A self-addressable microelectronic device is designed and fabricated to actively carry out and control multi-step and multiplex molecular biological reactions in microscopic formats.
Patent PT-778891-E (PT)
Inventor: KACZOREK MICHEL
IPC: C12N15/13
Filed: 1995-09-01
Abstract: Cloning of DNA fragments which code for the light chain or the heavy chain variable domain of the D7C2 monoclonal antibody within a baculovirus. The invention also concerns the expression of these DNA fragments in insect host cells, the anti-rhesus D recombinant monoclonal antibody so obtained and its use.
Patent PT-837810-E (PT)
Inventor: TERRY JEFF M
IPC: B62D53/10
Filed: 1995-12-28
Abstract: A novel interconnection of the jaw (42), wedge (26) and operating handle (21) in a fifth wheel (11) facilitates the provision of an indicator (58) on a secondary locking mechanism which further insures the security of the system. In the invention, the jaw (42) is connected to the operating handle (21) by a pivoting timing lever (31) which pivots off a pin (41) on the jaw (42) such that the jaw (42) remains engaged with the fifth wheel (11) until the wedge (26) is substantially removed from engagement with the jaw (42). In cooperation with the primary locking mechanism, a secondary lock is provided at the end of the operating handle (21) such that a pawl arrangement (51) engages a stop (63) on the fifth wheel assembly (11) until positively released by the operator. The pawl arrangement (51) further has a mechanical indicator (58) which extends beyond the fifth wheel assembly (11) and allows the operator to determine whether the king pin (16) is engaged and the secondary lock is activated. <IMAGE>
Patent PT-752248-E (PT)
Inventor: ANDERSON DARRELL R
IPC: C12P21/08
Filed: 1993-11-12
Abstract: Disclosed herein is an immunologically active, chimeric anti-CD20 antibody for use as a medicament, which antibody is capable of substantial B-cell depletion when administered to a subject.
Patent PT-885323-E (PT)
Inventor: CLODIC DENIS
IPC: D06F34/14
Filed: 1997-03-07
Abstract: PCT No. PCT/FR97/00408 Sec. 371 Date Aug. 31, 1998 Sec. 102(e) Date Aug. 31, 1998 PCT Filed Mar. 7, 1997 PCT Pub. No. WO97/33032 PCT Pub. Date Sep. 12, 1997A method and an apparatus is described for drying a load of moist fibrous material, particularly a load of laundry washed and placed in a washer/drier machine or a clothes drier, wherein a closed-circuit flow of superheated steam at 102-180 DEG  C. and substantially at atmospheric pressure is passed through the load of fibrous material. The method is characterized in that, prior to the superheated steam drying step, the air in the closed circuit is flushed therefrom with steam.
Patent PT-934168-E (PT)
Inventor: SIMS CHARLES ROBERT
IPC: B41J3/407
Filed: 1997-09-16
Abstract: The invention relates to a tape printing apparatus for printing an image on an image receiving tape. In order to detect characteristics of the tape thus avoiding representation means on a tape cassette, it is proposed to have detecting means for detecting-markings provided on the image receiving tape, which provide information on a characteristic of the tape; and the tape printing apparatus is controlled in accordance with the detected characteristics. Alternatively, it is proposed to have monitoring means for monitoring the speed of the image receiving tape, which detect marking on the image receiving tape whereby the printing means is controlled in dependence on the detected speed. Consequently, the exact tape speed is considered for printing purposes, even when slippage between driving means and tape occurs.
Patent PT-892736-E (PT)
Inventor: WESTON TERENCE EDWARD
IPC: B65B3/00
Filed: 1997-03-27
Abstract: A needleless injector drug capsule assembly comprising a container, housing therefor, a piston, and resilient seals to permit filling and sealing thereafter to maintain sterility of the contents.
Patent PT-925064-E (PT)
Inventor: LORIA ROGER M
IPC: A61K31/513
Filed: 1997-04-10
Abstract: The instant invention provides means of accelerating cell aging and programmed cell death in tumor cells by administration of 3 beta ,17 alpha  androstenediol ( alpha AED) or its ethers or esters.
Patent PT-922668-E (PT)
Inventor: DRIVON GILLES
IPC: B01J19/02
Filed: 1998-12-08
Abstract: Hydrogen bromide is produced by igniting a hydrogen/oxidant flame, replacing the oxidant with bromine vapor while maintaining a stable flame, cooling the combustion gases and recovering hydrogen bromide gas. Hydrogen bromide manufacturing equipment comprises a burner (1) which is supplied with bromine and/or oxidant (2) and with hydrogen (3) and which consists of a vertical tube within a vertical enclosure having a sequence of a cylindrical zone, a convergent frustoconical zone, a cylindrical zone and a divergent frustoconical zone with a height and a maximum diameter greater than those of the convergent zone. The equipment also includes a combustion chamber (4), a flame ignition system (5), a combustion gas cooling (6) and discharge (7, 8) system and safety devices (9, 10). An Independent claim is also included for the use of the above equipment in a hydrogen bromide manufacturing process comprising (a) forming an intimate mixture of hydrogen and an oxidant in an enclosure; (b) igniting a flame at the enclosure outlet; (c) replacing all or part of the oxidant with a prevaporized bromine stream while maintaining a stable flame for complete combustion of bromine in hydrogen; (d) cooling the combustion gases; and (e) recovering a hydrogen bromide gas stream at ≥ 1 bar absolute pressure and at  NOTGREATER  125 (preferably 40-125) degrees C.
Patent PT-981369-E (PT)
Inventor: MICHAELI DOV
IPC: C07K14/72
Filed: 1998-05-12
Abstract: The invention concerns immunogens, immunogenic compositions and method for the treatment of gastrin-dependent tumors. The immunogens comprise a peptide from the CCK-B/gastrin-receptor conjugated to a spacer and to an immunogenic carrier. The immunogens are capable of inducing antibodies in vivo which bind to the CCK-B/gastrin-receptor in tumor cells, thereby preventing growth stimulating peptide hormones from binding to the receptors, and inhibiting tumor cell growth. The immunogens also comprise antibodies against the CCK-B/gastrin-receptor for passive immunization. The invention also concerns diagnostic methods for detecting gastrin-dependent tumors in vivo or from a tissue biopsy using the antibodies of the invention.
Patent PT-1178833-E (PT)
Inventor: YEAGER JAMES L
IPC: A61K9/00
Filed: 1999-05-13
Abstract: A topical composition of a semi-solid consistency suitable is provided for transdermal application of prostaglandin E1. The composition comprises prostaglandin E1, a penetration enhancer, a polysaccharide gum, a lipophilic compound, and an acidic buffer system. The penetration enhancer is an alkyl-2-(N,N-disubstituted amino)-alkanoate ester, an (N,N-disubstituted amino)-alkanol alkanoate, or a mixture of these. The lipophilic compound may be an aliphatic C1 to C8 alcohol, an aliphatic C8 to C30 ester, or a mixture of these. The composition includes a buffer system capable of providing a buffered pH value for said composition in the range of about 3 to about 7.4.
Patent PT-1086178-E (PT)
Inventor: SMITH PAUL JAMES
IPC: C12Q1/68
Filed: 1999-06-15
Abstract: There is disclosed a compound of formula (I) wherein each of X1 and X2 are independently NH-A-NR1R2, and wherein A is A C2-8 alkylene and R1 and R2 are independently selected from hydrogen, C1-4 alkyl, C2-4 hydroxy-alkyl and C2-4 aminoalkyl, or R1 and R2 together form a C2-6 alkylene group which with the nitrogen atom to which R1 and R2 are attached forms a heterocyclic ring, or an N-oxide derivative thereof, and wherein the compound (I) or its N-oxide derivative is optionally in the form of an acid salt derived from an organic or inorganic acid. Also disclosed is a method of its production and its uses, including its use in analyzing a cell or biological material and detecting the emitted fluorescence signal.
Patent PT-1124817-E (PT)
Inventor: ELSOHLY MAHAMOUD A
IPC: A61K31/35
Filed: 1999-10-26
Abstract: The present invention provides an economical and efficient process for converting delta-9-tetrahydrocannabinol to a variety of ester analogs. Delta-9-tetrahydrocannabinol is esterified by reaction with a carboxylic acid, an acid halide or an acid anhydride in the presence of a 4-aminopyridine either alone or in admixture with an organic amine such as a mono-, di-, or tri-alkyl amine.